Level Four Advisory Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,565	Closed	-$366K	–	773
2023 Q3	$366K	Buy	+17,565	New	+$366K	0.02%	529